INSIGHTS ON DRUG DEVELOPMENT
-
![Scientist examining microplate GettyImages-1387090964]( "Quantifying Endotoxins Via Absorbance Or Fluorescence")
Quantifying Endotoxins Via Absorbance Or FluorescenceFind out how endotoxin assays use Factor C activation to generate measurable absorbance or fluorescence signals, with guidance on selecting detection formats and implementing scalable workflows.
-
![Organs-body-organoid-study-GettyImages-1157550305]( "A Study To Assess Organoid Size And Cell Count From 3D Image Analysis")
A Study To Assess Organoid Size And Cell Count From 3D Image AnalysisRecent advancements in 3D patient-derived organoids (PDOs) offer improved predictive power over traditional 2D assays. Explore a patented bioprocess for PDO expansion that could revolutionize drug discovery, especially in oncology.
-
![GettyImages-1412800224-scientist-examining-filter-in-lab]( "How To Choose The Appropriate Filter Material For Every Sample")
How To Choose The Appropriate Filter Material For Every SampleMembrane compatibility plays a crucial role in reliable sample filtration. Knowing how different filter materials interact helps prevent common workflow issues and supports efficient filtration.
-
![GettyImages-899692706 Project Manager And Chief Engineer Using Laptop In Modern Factory]( "Project Management: Sphere Of Influence")
Project Management: Sphere Of InfluenceThe project manager's sphere of influence extends beyond the project team, encompassing the organization, industry, and professional discipline.
-
Lonza Advanced Synthesis Capabilities Update February 2026: AI Drug Development3/2/2026
Learn how our scientists accurately predict and identify the most stable cocrystal forms by leveraging advanced machine learning models, enhancing efficiency and reducing development risks.
-
Navigating Challenges During Formulation Development9/11/2024
Gain valuable knowledge on addressing formulation stability, improving product shelf life, and enhancing overall product performance in biopharmaceutical studies.
-
Transformative Innovation: Advancing Drug Development Using In Silico Modeling3/4/2026
Explore how predictive modeling and in silico strategies can turn complex data into actionable insights that accelerate drug development and reduce risk across the development lifecycle.
-
Chirality In Drug Development: From Racemic Mixtures To Enantiopure Substances5/6/2026
Chiral crystallization enables efficient production of enantiopure drug substances, improving pharmacological control and safety while supporting scalable, cost‑effective small molecule development.
-
Expanding Translational Research Concepts With Genedata Profiler11/26/2024
The biopharma industry leverages Genedata Profiler to integrate, curate, and analyze diverse R&D data, enabling collaborative, compliant, and AI-driven translational research to optimize drug development.
DRUG DEVELOPMENT SOLUTIONS
-
![GettyImages-1634050535 data, logistics]( "Cutting-Edge Data Integration And Analytics Platform")
Genedata Profiler empowers biopharma R&D by integrating, harmonizing, and analyzing diverse data, enhancing collaboration, accelerating insights, and reducing costs for precision medicine advancement.
-
![GettyImages-1214921728-lab-glassware-beaker-vial-test-tube]( "Enhance The Solubility Of Your APIs With AI")
When it comes to solid dosage formulations, the most common challenge formulators face is poor solubility. In numbers: 70% of drugs in development are poorly soluble.
-
![Upperton-Formulation Development]( "Formulation Development")
Upperton offers formulation development services to accelerate First-in-Human studies and advance projects toward clinical trials.
-
![paylinker-cdmo-GettyImages-1287846309]( "Payload-Linker")
Learn how high‑potency infrastructure, strong impurity control, and scalable payload‑linker capabilities help teams manage risk, maintain purity, and advance toward clinical‑stage ADC development.
-
![GettyImages-1293772880-Lab-Science-Research-Scientist-Discovery-Development]( "Empowering Biologics Development With HRMS Services")
Examine ways to accelerate biologic development with high-resolution mass spectrometry services that deliver precise, reliable data from discovery through commercial release.
